TaiGen Biopharmaceuticals Holdings Ltd (太景醫藥研發控股) yesterday said that it turned profitable last quarter on the back of a milestone payment of US$5 million for its hepatitis C drug Furaprevir.
TaiGen received the payment from its Chinese partner, Yichang HEC Changjiang Pharmaceutical Co (宜昌東陽光長江藥業), at the end of June after completing the phase II clinical trial in China in April, communication manager Grace Wang (王暄茹) said by telephone.
“The cure rate was good in the phase II trial,” Wang said, adding that the company started the phase III trial in China in June.
“We expect to enroll a total of 360 patients as required by the regulator by the end of this year and hope to complete the trial next year,” she said.
According to their agreement, Yichang would make a milestone payment of US$5 million for each of the following — when TaiGen completes the final-stage trial, submits its application for marketing approval and gains regulatory approval — or a total of US$15 million over the next few years, Wang said.
TaiGen posted a net profit of NT$60.45 million (US$1.92 million) in the second quarter, bringing its total profit in the first half of the year to NT$6.37 million, compared with net losses of NT$122 million a year earlier, company data showed.
That translated into earnings per share of NT$0.01.
Contributing to its first-half performance were sales of the oral version of antibiotic Taigexyn, which surged 258 percent year-on-year after its marketing partner managed to tap into about 200 hospitals in China, Wang said.
TaiGen received marketing approval for the oral formulation in 2016 and expects sales of the drug to continue growing in the following years, she said.
The company is still waiting for Chinese authorities to finish their review of its injectable formulation of Taigexyn, which would generate higher profits as its price would be at least eight times higher than that of the oral formula, Wang said.
The injectable formulation is likely to be more popular as Chinese generally favor it over oral formulations, she said.
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has appointed Rose Castanares, executive vice president of TSMC Arizona, as president of the subsidiary, which is responsible for carrying out massive investments by the Taiwanese tech giant in the US state, the company said in a statement yesterday. Castanares will succeed Brian Harrison as president of the Arizona subsidiary on Oct. 1 after the incumbent president steps down from the position with a transfer to the Arizona CEO office to serve as an advisor to TSMC Arizona’s chairman, the statement said. According to TSMC, Harrison is scheduled to retire on Dec. 31. Castanares joined TSMC in
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the